InsightfulValue
← Home

AbbVie
AbbVie

-13.15%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

AbbVie

πŸ“Š Get full analytics about AbbVie

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

Price
Live  
Overview
AbbVie is a global, research-driven biopharmaceutical company that was founded in 2013 when it spun off from Abbott Laboratories. The company's focus is on developing advanced therapies and medicines for conditions such as immunology, oncology, neuroscience, and virology.
Headquartered in North Chicago, Illinois, AbbVie employs approximately 48,000 people worldwide and operates in more than 75 countries. The company is dedicated to providing innovative, safe, and effective treatments for patients, and its products are available in over 170 countries.
AbbVie's mission is to discover and deliver breakthrough medicines that enable people to live better lives. The company's values include integrity, collaboration, innovation, and a commitment to patient well-being. AbbVie has a strong pipeline of medications in various stages of development, and the company invests heavily in research and development to bring new treatments to patients.
Some of AbbVie's notable products include Humira, the best-selling prescription medication in the world, used to treat autoimmune conditions such as rheumatoid arthritis and Crohn's disease, and Imbruvica, a targeted therapy for certain types of cancers. The company also has a portfolio of other medicines and treatments for conditions such as hepatitis C, multiple sclerosis, and Parkinson's disease.
AbbVie is committed to giving back to communities by supporting various charitable and scientific organizations. The company's philanthropic efforts focus on initiatives that align with its areas of expertise, such as healthcare, education, and environmental sustainability.
In addition to its focus on research and patient care, AbbVie is also committed to operating ethically and responsibly. The company has stated its commitment to reducing its environmental impact, promoting diversity and inclusion, and upholding rigorous ethical standards in all its operations.
Overall, AbbVie is a leading, globally recognized biopharmaceutical company with a strong portfolio and a commitment to making a positive impact in the world.
What is special about the company?
AbbVie

πŸ“ˆ Want to read more about AbbVie?

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlcmUgYX JlIHNldmVy YWwgbm90ZX dvcnRoeSBh c3BlY3RzIG 9mIHRoZSBB YmJWaWUgY2 9tcGFueSB0 aGF0IG1ha2 UgaXQgc3Rh bmQgb3V0IG Zyb20gb3Ro ZXIgcGhhcm 1hY2V1dGlj YWwgY29tcG FuaWVzOjxi cj4xLiBGb2 N1cyBvbiBp bm5vdmF0aX ZlIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudDogQW JiVmllIHBs YWNlcyBhIH N0cm9uZyBl bXBoYXNpcy BvbiBkaXNj b3ZlcmluZy BhbmQgZGV2 ZWxvcGluZy BuZXcgdHJl YXRtZW50cy Bmb3IgY2hh bGxlbmdpbm cgaGVhbHRo IGNvbmRpdG lvbnMuIFRo ZSBjb21wYW 55IGludmVz dHMgaGVhdm lseSBpbiBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn QsIHdpdGgg YSBzaWduaW ZpY2FudCBw b3J0aW9uIG 9mIGl0cyBy ZXZlbnVlIG JlaW5nIGFs bG9jYXRlZC B0byB0aGlz IGFyZWEuPG JyPjIuIFN0 cm9uZyBwb3 J0Zm9saW8g b2YgbGVhZG luZyBtZWRp Y2luZXM6IE FiYlZpZSBo YXMgYSByb2 J1c3QgcG9y dGZvbGlvIG 9mIG1lZGlj aW5lcyB0aG F0IGFkZHJl c3MgYSBkaX ZlcnNlIHJh bmdlIG9mIG Rpc2Vhc2Vz LCBpbmNsdW RpbmcgaW1t dW5vbG9neS wgbmV1cm9s b2d5LCBvbm NvbG9neSwg YW5kIHZpcm 9sb2d5LiBN YW55IG9mIG l0cyBwcm9k dWN0cyBhcm UgY29uc2lk ZXJlZCBiZX N0LWluLWNs YXNzIGluIH RoZWlyIHJl c3BlY3Rpdm UgdGhlcmFw ZXV0aWMgYX JlYXMuPGJy PjMuIFN0cm 9uZyBwaXBl bGluZTogSW 4gYWRkaXRp b24gdG8gaX RzIGN1cnJl bnQgbGluZS BvZiBtZWRp Y2luZXMsIE FiYlZpZSBo YXMgYSBzdH JvbmcgcGlw ZWxpbmUgb2 YgcG90ZW50 aWFsIG5ldy B0cmVhdG1l bnRzLCB3aG ljaCBpdCBj b250aW51b3 VzbHkgZXZh bHVhdGVzIG ZvciB0aGVp ciBwb3Rlbn RpYWwgdG8g YWRkcmVzcy B1bm1ldCBt ZWRpY2FsIG 5lZWRzIGFu ZCBjcmVhdG UgdmFsdWUg Zm9yIHBhdG llbnRzLjxi cj40LiBDb2 1taXRtZW50 IHRvIHBhdG llbnQgY2Fy ZTogQWJiVm llIGlzIGNv bW1pdHRlZC B0byBtYWtp bmcgYSBtZW FuaW5nZnVs IGRpZmZlcm VuY2UgaW4g dGhlIGxpdm VzIG9mIHBh dGllbnRzIG J5IHByb3Zp ZGluZyBhY2 Nlc3MgdG8g aW5ub3ZhdG l2ZSBtZWRp Y2luZXMgYW 5kIHN1cHBv cnRpbmcgZG lzZWFzZSBl ZHVjYXRpb2 4gYW5kIGF3 YXJlbmVzcy Bwcm9ncmFt cy48YnI+NS 4gU3VzdGFp bmFiaWxpdH kgaW5pdGlh dGl2ZXM6IF RoZSBjb21w YW55IGhhcy BhIHN0cm9u ZyBmb2N1cy BvbiBzdXN0 YWluYWJpbG l0eSBhbmQg aGFzIGltcG xlbWVudGVk IHNldmVyYW wgaW5pdGlh dGl2ZXMgdG 8gcmVkdWNl IGVudmlyb2 5tZW50YWwg aW1wYWN0LC Bwcm9tb3Rl IGVtcGxveW VlIHdlbGwt YmVpbmcsIG FuZCBzdXBw b3J0IGxvY2 FsIGNvbW11 bml0aWVzLj xicj42LiBT dHJvbmcgZm luYW5jaWFs IHBlcmZvcm 1hbmNlOiBB YmJWaWUgaG FzIGNvbnNp c3RlbnRseS BkZWxpdmVy ZWQgc3Ryb2 5nIGZpbmFu Y2lhbCByZX N1bHRzLCB3 aXRoIGEgdH JhY2sgcmVj b3JkIG9mIH N1c3RhaW5h YmxlIGxvbm ctdGVybSBn cm93dGggYW 5kIHNoYXJl aG9sZGVyIH ZhbHVlIGNy ZWF0aW9uLj xicj43LiBH bG9iYWwgcH Jlc2VuY2U6 IEFiYlZpZS BvcGVyYXRl cyBpbiBtb3 JlIHRoYW4g MTc1IGNvdW 50cmllcyBh bmQgaGFzIG Egc3Ryb25n IGdsb2JhbC BwcmVzZW5j ZSwgd2hpY2 ggZW5hYmxl cyBpdCB0by ByZWFjaCBh IHdpZGUgcG F0aWVudCBw b3B1bGF0aW 9uIGFuZCBj b250cmlidX RlIHRvIGlt cHJvdmluZy BnbG9iYWwg aGVhbHRoIG 91dGNvbWVz Lg==
What the company's business model?
AbbVie

πŸ“ˆ Want to read more about AbbVie?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

QWJiVmllIG lzIGEgYmlv cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IGZv Y3VzZXMgb2 4gdGhlIGRl dmVsb3BtZW 50LCBtYW51 ZmFjdHVyaW 5nLCBhbmQg Y29tbWVyY2 lhbGl6YXRp b24gb2YgaW 5ub3ZhdGl2 ZSBwaGFybW FjZXV0aWNh bCBwcm9kdW N0cyBwcmlt YXJpbHkgaW 4gdGhlIGFy ZWFzIG9mIG ltbXVub2xv Z3ksIG9uY2 9sb2d5LCBu ZXVyb3NjaW VuY2UsIGFu ZCB2aXJvbG 9neS4gPGJy PlRoZSBjb2 1wYW55J3Mg YnVzaW5lc3 MgbW9kZWwg aXMgY2VudG VyZWQgYXJv dW5kIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCAo UiZEKSBvZi BuZXcgbWVk aWNpbmVzIG FuZCB0aGVy YXBpZXMsIH N0cmF0ZWdp YyBjb2xsYW JvcmF0aW9u cyBhbmQgcG FydG5lcnNo aXBzLCBhbm QgYSBzdHJv bmcgc2FsZX MgYW5kIG1h cmtldGluZy BzdHJhdGVn eSB0byBicm luZyB0aGVz ZSBwcm9kdW N0cyB0byBt YXJrZXQuID xicj5BYmJW aWUncyBSJk QgZWZmb3J0 cyBhcmUgZm 9jdXNlZCBv biBpZGVudG lmeWluZyBw b3RlbnRpYW wgdHJlYXRt ZW50cyBmb3 IgZGlzZWFz ZXMgd2l0aC B0aGUgZ3Jl YXRlc3QgdW 5tZXQgbmVl ZHMsIHVzaW 5nIGN1dHRp bmctZWRnZS B0ZWNobm9s b2dpZXMgYW 5kIGlubm92 YXRpdmUgYX Bwcm9hY2hl cy4gVGhlIG NvbXBhbnkg aGFzIGEgcm 9idXN0IHBp cGVsaW5lIG 9mIHByb21p c2luZyBkcn VnIGNhbmRp ZGF0ZXMgaW 4gdmFyaW91 cyBzdGFnZX Mgb2YgZGV2 ZWxvcG1lbn QuIDxicj5J biBhZGRpdG lvbiwgQWJi VmllIGhhcy Blc3RhYmxp c2hlZCBzdH JhdGVnaWMg Y29sbGFib3 JhdGlvbnMg YW5kIHBhcn RuZXJzaGlw cyB3aXRoIG xlYWRpbmcg b3JnYW5pem F0aW9ucyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeSB0byBj b21wbGVtZW 50IGl0cyBp bi1ob3VzZS BSJkQgZWZm b3J0cyBhbm QgYWR2YW5j ZSBpdHMgZH J1ZyBkaXNj b3ZlcnkgYW 5kIGRldmVs b3BtZW50IH Byb2dyYW1z LiBUaGlzIG luY2x1ZGVz IHBhcnRuZX JzaGlwcyB3 aXRoIGFjYW RlbWljIGlu c3RpdHV0aW 9ucywgYmlv dGVjaCBjb2 1wYW5pZXMs IGFuZCBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMuID xicj5BYmJW aWUgYWxzby BoYXMgYSBz dHJvbmcgc2 FsZXMgYW5k IG1hcmtldG luZyBzdHJh dGVneSB0by Bkcml2ZSB0 aGUgY29tbW VyY2lhbCBz dWNjZXNzIG 9mIGl0cyBw cm9kdWN0cy 4gVGhlIGNv bXBhbnkgaG FzIGEgZ2xv YmFsIHByZX NlbmNlIGFu ZCBhIGRpdm Vyc2lmaWVk IHBvcnRmb2 xpbyBvZiBk cnVncywgd2 hpY2ggYWxs b3dzIGl0IH RvIGxldmVy YWdlIGl0cy BvcGVyYXRp b25zIGFuZC ByZXNvdXJj ZXMgaW4gZG lmZmVyZW50 IG1hcmtldH MuIDxicj5P dmVyYWxsLC B0aGUgQWJi VmllIGJ1c2 luZXNzIG1v ZGVsIGlzIG ZvY3VzZWQg b24gZGV2ZW xvcGluZyBh bmQgYnJpbm dpbmcgaW5u b3ZhdGl2ZS BtZWRpY2lu ZXMgdG8gcG F0aWVudHMg aW4gbmVlZC wgd2hpbGUg YWxzbyBkcm l2aW5nIHBy b2ZpdGFibG UgZ3Jvd3Ro IHRocm91Z2 ggc291bmQg UiZELCBwYX J0bmVyc2hp cHMsIGFuZC Bjb21tZXJj aWFsaXphdG lvbiBzdHJh dGVnaWVzLg ==
Interesting facts about the company
AbbVie

πŸ“ˆ Want to read more about AbbVie?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvWE E4UGdOTTI1 RTBlS3NEVW 1ySEQud2Vi cCIgYWx0PS JBYmJWaWUi IHRpdGxlPS JBYmJWaWUi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgQWJiVmll PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TmiBZ b3VyIGZyZW UgY29weSBv ZiA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGlz IHdhaXRpbm cKICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9wPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxMnB4 OyBmb250LX NpemU6IDEz cHg7IGNvbG 9yOiAjNDQ0 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIG5vdyBh bmQgZ2V0IG 91ciBmcmVl IGVCb29rIA ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG I+VGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrczwvYj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDE2cHg7IG ZvbnQtc2l6 ZTogMTRweD sgY29sb3I6 ICM0NDQ7IG ZvbnQtZmFt aWx5OiAtYX BwbGUtc3lz dGVtLCBCbG lua01hY1N5 c3RlbUZvbn QsIFNlZ29l IFVJLCBSb2 JvdG8sIEhl bHZldGljYS BOZXVlLCBz YW5zLXNlcm lmOyBsaW5l LWhlaWdodD ogMS42Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBI YXZlIHlvdS BoZWFyZCBh Ym91dCBvdX Igc2hvcnQg PHN0cm9uZy BzdHlsZT0n Zm9udC13ZW lnaHQ6IDYw MDsnPkRhaW x5IFZpZGVv IE5ld3NsZX R0ZXI8L3N0 cm9uZz4/Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdo dHRwczovL3 d3dy5pbnNp Z2h0ZnVsdm FsdWUuY29t L25ld3NsZX R0ZXIucGhw JyB0YXJnZX Q9J19ibGFu aycgc3R5bG U9J2NvbG9y OiAjMDA3Qk ZGOyB0ZXh0 LWRlY29yYX Rpb246IG5v bmU7IGZvbn Qtd2VpZ2h0 OiA1MDA7IG 1hcmdpbi1s ZWZ0OiA2cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBG aW5kIG91dC Btb3JlCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgCi AgICAgICAg CiAgICAgIC AgPHNwYW4g Y2xhc3M9J2 JsdXJyZWQt dGV4dCc+Ci AgICAgICAg ICAgIE1TNG dRV0ppVm0g bGxJSGRoY3 lCaiBjbVZo ZEdWa0lHIE Z6SUdFZ2Mz QnAgYm05bV ppQmpiMiAx d1lXNTVJR1 p5IGIyMGdR V0ppYjMgUj BJRXhoWW05 eSBZWFJ2Y2 1sbGN5IEJw YmlBeU1ERX ogTENCdFlX dHBibSBjZ2 FYUWdZU0J5 IFpXeGhkR2 wyWlcgeDVJ SGx2ZFc1bi BJR052YlhC aGJuIGtnWT I5dGNHRnkg WldRZ2RHOG diMyBSb1pY SnpJR2x1IE lIUm9aU0J3 YUcgRnliV0 ZqWlhWMCBh V05oYkNCcG JtIFIxYzNS eWVTNDggWW 5JK01pNGdW RyBobElHNW hiV1VnIFFX SmlWbWxsSU cgbHpJR1Js Y21sMiBaV1 FnWm5KdmJT IEJoSUdOdm JXSnAgYm1G MGFXOXVJRy A5bUlIUm9a U0IzIGIzSm tjeUJCWW0g SnZkSFFnWV c1ayBJSFpw ZEdGc2FYIF I1TGp4aWNq NHogTGlCQl ltSldhVyBY aWdKbHpJR2 hsIFlXUnhk V0Z5ZEcgVn ljeUJoY21V ZyBiRzlqWV hSbFpDIEJw YmlCT2IzSj AgYUNCRGFH bGpZVyBkdk xDQkpiR3hw IGJtOXBjeT Q4WW4gSStO QzRnVkdobC BJR052YlhC aGJuIGtnWl cxd2JHOTUg Y3lCdmRtVn lJRCBRM0xE QXdNQ0J3IF pXOXdiR1Vn ZDIgOXliR1 IzYVdSbCBJ R0Z1WkNCb1 lYIE1nWVNC d2NtVnogWl c1alpTQnBi aSBCdGIzSm xJSFJvIFlX NGdNVGN3SU cgTnZkVzUw Y21sbCBjeT Q4WW5JK05T IDRnUVdKaV ZtbGwgNG9D WmN5QndjbS BsdFlYSjVJ R1p2IFkzVn pJR2x6SUcg OXVJR1JsZG 1WcyBiM0Jw Ym1jZ1lXID VrSUcxaGJu Vm0gWVdOMG RYSnBibSBj Z2NHaGhjbT FoIFkyVjFk R2xqWVcgd2 djSEp2WkhW aiBkSE1nYV c0Z2RHIGhs SUdGeVpXRn ogSUc5bUlH bHRiWCBWdW IyeHZaM2tz IElHOXVZMj lzYjIgZDVM Q0J1WlhWeS BiM05qYVdW dVkyIFVzSU hacGNtOXMg YjJkNUxDQm hibSBRZ1oy VnVaWEpoIG JDQnRaV1Jw WTIgbHVaUz Q4WW5JKyBO aTRnVkdobE lHIE52YlhC aGJubmkgZ0 pseklIUnZj QyAxelpXeH NhVzVuIElH UnlkV2NnYV ggTWdTSFZ0 YVhKaCBMQ0 JoSUcxbFpH IGxqWVhScG IyNGcgZFhO bFpDQjBieS BCMGNtVmhk Q0JoIGRYUn ZhVzF0ZFcg NWxJR1JwYz I5eSBaR1Z5 Y3lCemRXIE 5vSUdGeklI Sm8gWlhWdF lYUnZhVyBR Z1lYSjBhSE pwIGRHbHpM Q0J3YzIgOX lhV0Z6YVhN cyBJR0Z1Wk NCRGNtIDlv YnVLQW1YTW cgWkdselpX RnpaUyA0OF luSStOeTRn IFFXSmlWbW xsSUcgaGhj eUJ0WVdSbC BJSE5wWjI1 cFptIGxqWV c1MElHbHUg ZG1WemRHMW xibiBSeklH bHVJSFJvIF pTQm1hV1Zz WkMgQnZaaU JpYVc5MCBa V05vYm05c2 IyIGQ1TENC d1lYSjAgYV dOMWJHRnli SCBrZ2FXNG dkR2hsIElH RnlaV0Z6SU cgOW1JR05o Ym1ObCBjaU JoYm1RZ2FX IDF0ZFc1dm JHOW4gZVN3 Z2RHaHliMy BWbmFDQndZ WEowIGJtVn ljMmhwY0gg TWdZVzVrSU dGaiBjWFZw YzJsMGFXID l1Y3k0OFlu SSsgT0M0Z1 NXNGdNaiBB eE9Td2dRV0 ppIFZtbGxJ R052YlggQn NaWFJsWkNC aCBJQ1EyTX lCaWFXIHhz YVc5dUlHRm ogY1hWcGMy bDBhVyA5dU lHOW1JRUZz IGJHVnlaMk Z1TEMgQmhJ R2RzYjJKaC BiQ0J3YUdG eWJXIEZqWl hWMGFXTmgg YkNCamIyMX dZVyA1NUlH dHViM2R1IE lHWnZjaUJw ZEggTWdRbT kwYjNnZyBZ bkpoYm1RdV BHIEp5UGpr dUlFRmkgWW xacFpTQm9Z WCBNZ1lTQn pkSEp2IGJt Y2dZMjl0Yl cgbDBiV1Z1 ZENCMCBieU J6ZFhOMFlX IGx1WVdKcG JHbDAgZVNC aGJtUWdhRy BGeklHSmxa VzRnIGNtVm piMmR1YVgg cGxaQ0JtYj NJZyBhWFJ6 SUdWbVptID l5ZEhNZ2FX NGcgY21Wa2 RXTnBibSBj Z2FYUnpJR1 Z1IGRtbHli MjV0WlcgNT BZV3dnYVcx dyBZV04wSU hSb2NtIDkx WjJnZ2FXNX AgZEdsaGRH bDJaWCBNZ2 MzVmphQ0Jo IGN5QjFjMm x1WnkgQnla VzVsZDJGaS BiR1VnWlc1 bGNtIGQ1SU dGdVpDQnkg WldSMVkybH VaeSBCM1lY UmxjaUJqIG IyNXpkVzF3 ZEcgbHZiaT Q4WW5JKyBN VEF1SUZSb1 pTIEJqYjIx d1lXNTUgSU doaGN5QmhJ RyBocGMzUn ZjbmtnIGIy WWdjR2hwYk cgRnVkR2h5 YjNCNSBJR0 Z1WkNCb1lY IE1nWkc5dV lYUmwgWkNC dGFXeHNhVy A5dWN5QnZa aUJrIGIyeH NZWEp6SUgg UnZJSFpoY2 1sdiBkWE1n WTJGMWMyIF Z6SUdGdVpD QnYgY21kaG JtbDZZWCBS cGIyNXpMQ0 JwIGJtTnNk V1JwYm0gY2 dkR2h2YzJV ZyBabTlqZF hObFpDIEJ2 YmlCb1pXRn MgZEdnZ1ky RnlaUyB3Z1 pXUjFZMkYw IGFXOXVMQ0 JoYm0gUWdj bVZtZFdkbC BaU0JoYzNO cGMzIFJoYm 1ObExnPT0K ICAgICAgIC A8L3NwYW4+ CiAgICAgIC AgCiAgICAg ICAg
See Company Q&A
AbbVie

πŸ“Š Get full analytics about AbbVie

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal